Peritoneal carcinomatosis
MONDO:0700336Cancer in which a carcinoma, usually of the digestive tract or female reproductive organs, has spread extensively throughout the peritoneum and causes tumors to grow on the peritoneum. Peritoneal carcinomatosis can happen in many types of cancer, but it is most common in people with cancers of the ovary, colon, rectum, stomach, pancreas, or appendix.
Also known as: abdominal carcinomatosis, carcinomatosis of the peritoneum, peritoneal carcinomatosis
2828 clinical trials for this condition and its sub-types, 90 tagged with Peritoneal carcinomatosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Peritoneal carcinomatosis
-
Pseudomyxoma peritonei 17 trials
-
Can surgery after drug therapy beat drugs alone for stomach cancer spread?
Disease control Not yet recruitingThis trial tests whether adding radical surgery to remove the stomach tumor and nearby lymph nodes improves survival and quality of life compared with continuing drug therapy alone in patients with stomach cancer that has spread to the abdominal lining (peritoneal metastasis) and…
Phase 3 • Sponsor: Hua Huang, MD, PhD • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a Triple-Action therapy tackle stomach Cancer's spread?
Disease control Not yet recruitingThis phase II trial is testing whether a combination of low-dose radiation, an immunotherapy drug (serplulimab), and chemotherapy can help people with stomach cancer that has spread to the lining of the abdomen (peritoneal metastasis). The study enrolls adults with HER2-negative …
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New cocktail of drugs and vaccines takes on advanced ovarian cancer
Disease control Not yet recruitingThis phase 2 trial is testing a new, intensive treatment plan for 28 people with advanced ovarian cancer. The approach combines chemotherapy given into the abdomen and vein, a special vaccine made from the patient's own immune cells, and the immunotherapy drug Keytruda. The goal …
Phase 2 • Sponsor: Kalinski, Pawel, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New radiation technique targets stomach and ovarian cancer spread without surgery
Disease control Not yet recruitingThis study tests a precise radiation therapy guided by MRI for people with up to 5 spots of cancer spread in the abdomen from stomach, bowel, or ovarian cancers. About 34 adults will receive this non-invasive treatment to shrink tumors and delay the need for chemotherapy. The goa…
Phase 2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy targets abdominal cancer spread in early trial
Disease control Not yet recruitingThis early-stage study tests a new treatment plan for people with stomach or colorectal cancer that has spread to the lining of the abdomen. The approach combines low-dose radiation to the whole abdomen with chemotherapy and an immunotherapy drug. The main goal is to check if the…
Phase 1 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy targets Stomach-Lining cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug combination (PX plus nab-paclitaxel) given directly into the abdomen for people with a type of advanced cancer that has spread to the lining of the belly. The main goal is to find a safe dose and check for side effects. About 22 adults with…
Phase 1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a constipation drug help keep colorectal cancer at bay?
Disease control Not yet recruitingThis phase II trial is testing whether adding lubiprostone, a drug usually used for constipation, to standard maintenance therapy can delay cancer recurrence in adults with colorectal cancer that has spread to the lining of the abdomen. About 124 participants who have had surgery…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New spray chemotherapy trial targets Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThis study tests a method called PIPAC, where the chemotherapy drug paclitaxel is turned into a pressurized spray and delivered directly into the abdomen. It is for women with ovarian cancer that has come back and no longer responds to platinum-based chemotherapy. The trial has t…
Phase 1/2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New cocktail of drugs aims to shrink Hard-to-Treat abdominal tumors
Disease control Not yet recruitingThis Phase 2 trial tests whether adding pirfenidone and sintilimab to standard chemotherapy can shrink tumors in 30 people with colorectal cancer that has spread to the lining of the abdomen. Participants will receive the drug combination before any other treatment. The study wil…
Phase 2 • Sponsor: Guoxiang Cai • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can starting prehab early boost ovarian cancer outcomes?
Symptom relief Not yet recruitingThis study compares two types of prehabilitation (exercise, nutrition, and psychological support) for 225 women with advanced ovarian cancer. One group starts prehab early during chemotherapy, while the other starts just before surgery. The goal is to see if early prehab reduces …
Sponsor: Hospital Clinic of Barcelona • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Fish oil drink before surgery may cut complications, tiny study hints
Symptom relief Not yet recruitingThis pilot study tests whether drinking an omega-3-enriched nutritional supplement for 21 days before surgery can reduce complications in people with abdominal cancer. 28 patients will be randomly assigned to get either the omega-3 drink or a standard supplement. Researchers will…
Sponsor: Catholic University of the Sacred Heart • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Chewing gum may soothe chemo nausea: new study tests ginger and cinnamon
Symptom relief Not yet recruitingThis study tests whether chewing ginger-mint or cinnamon gum can reduce nausea and vomiting after a specific chemotherapy procedure (PIPAC) for colorectal cancer that has spread to the abdomen. 75 adults will be randomly assigned to chew one of the two flavored gums or receive st…
Sponsor: Fenerbahce University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New study aims to predict who benefits from abdominal cancer surgery
Knowledge-focused Not yet recruitingThis study looks at how colorectal cancer grows when it spreads to the lining of the abdomen. Researchers want to see if the pattern of tumor growth can help doctors decide who will benefit most from surgery. The study will follow 30 adults who are already scheduled for surgery o…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Eye test for surgeons: can they spot cancer clues?
Knowledge-focused Not yet recruitingThis study checks if surgeons can tell key details about ovarian cancer by looking at images from a camera inside the belly. About 70-80 surgeons will review pictures from 19 patients and guess the cancer type and growth pattern. The goal is to see if visual clues can help plan t…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New study aims to catch ovarian cancer spread earlier with deeper tissue sampling
Knowledge-focused Not yet recruitingThis study tests whether removing a larger piece of the pelvic lining during surgery can find tiny cancer deposits that standard biopsies might miss. About 390 adults with early-stage ovarian or fallopian tube cancer will undergo this procedure. The goal is to improve staging acc…
Sponsor: Ospedale Santa Croce-Carle Cuneo • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC